Patents by Inventor Kenneth Weisman

Kenneth Weisman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dutasteride to prevent and treat atherosclerosis
    Patent number: 6630164
    Abstract: A method of decreasing atherosclerosis and its complications including but not limited to myocardial infarction, stroke, and peripheral vascular disease comprising administering to a human or animal an amount of dutasteride sufficient to decrease atherosclerosis and its complications.
    Type: Grant
    Filed: May 8, 2001
    Date of Patent: October 7, 2003
    Inventors: Kenneth Weisman, Michael E. Goldberg
  • Use of saw palmetto to prevent atherosclerosis
    Patent number: 6627227
    Abstract: A method of decreasing atherosclerosis and its complications including but not limited to myocardial infarction, stroke, and peripheral vascular disease comprising administering to a human or animal an amount of saw palmetto or Permixon containing saw palmetto sufficient to decrease atherosclerosis and its complications.
    Type: Grant
    Filed: May 8, 2001
    Date of Patent: September 30, 2003
    Inventors: Kenneth Weisman, Michael E. Goldberg
  • Use of HMG-COA reductase inhibitors to prevent and treat BPH
    Patent number: 6534537
    Abstract: A method of preventing and treating benign prostatic hypertrophy or benign prostatic hyperplasia wherein the method involves administering to a human or an animal a sufficient amount of a HMG Co-A Reductase Inhibitor.
    Type: Grant
    Filed: January 5, 2001
    Date of Patent: March 18, 2003
    Inventors: Kenneth Weisman, Michael E. Goldberg
  • Therapeutic uses of hormonal manipulation using combinations of various agents to treat atherosclerosis
    Patent number: 6479063
    Abstract: A method of decreasing atherosclerosis and its complications involving administering to a human or animal various combinations of medications with Finasteride, Bicalutamide, Flutamide and Nilutamide.
    Type: Grant
    Filed: December 26, 2000
    Date of Patent: November 12, 2002
    Inventors: Kenneth Weisman, Michael E. Goldberg
  • Therapeutic uses of hormonal manipulation using combinations of various agents to treat atherosclerosis
    Publication number: 20020006399
    Abstract: A method of decreasing atherosclerosis and its complications involving administering to a human or animal various combinations of medications with Finasteride, Bicalutamide, Flutamide and Nilutamide.
    Type: Application
    Filed: December 26, 2000
    Publication date: January 17, 2002
    Inventors: Kenneth Weisman, Michael E. Goldberg
  • Use of HMG-COA reductase inhibitors to prevent and treat BPH
    Publication number: 20020004521
    Abstract: A method of preventing and treating benign prostatic hypertrophy or benign prostatic hyperplasia wherein the method involves administering to a human or an animal a sufficient amount of a HMG Co-A Reductase Inhibitor.
    Type: Application
    Filed: January 5, 2001
    Publication date: January 10, 2002
    Inventors: Kenneth Weisman, Michael E. Goldberg
  • Use of saw palmetto to prevent atherosclerosis
    Publication number: 20010053391
    Abstract: A method of decreasing atherosclerosis and its complications including but not limited to myocardial infarction, stroke, and peripheral vascular disease comprising administering to a human or animal an amount of saw palmetto or Permixon containing saw palmetto sufficient to decrease atherosclerosis and its complications.
    Type: Application
    Filed: May 8, 2001
    Publication date: December 20, 2001
    Inventors: Kenneth Weisman, Michael E. Goldberg
  • Dutasteride to prevent and treat atherosclerosis
    Publication number: 20010048942
    Abstract: A method of decreasing atherosclerosis and its complications including but not limited to myocardial infarction, stroke, and peripheral vascular disease comprising administering to a human or animal an amount of dutasteride sufficient to decrease atherosclerosis and its complications.
    Type: Application
    Filed: May 8, 2001
    Publication date: December 6, 2001
    Inventors: Kenneth Weisman, Michael E. Goldberg
  • Therapeutic uses of abarelix
    Patent number: 6197337
    Abstract: A method of decreasing atherosclerosis and its complications including but not limited to myocardial infarction, stroke and peripheral vascular disease wherein the method involves administering to a human or an animal an amount of abarelix sufficient to reduce atherosclerosis and its complications.
    Type: Grant
    Filed: May 9, 2000
    Date of Patent: March 6, 2001
    Inventors: Kenneth Weisman, Michael E. Goldberg
  • Female voiding assist device and method
    Patent number: 5176664
    Abstract: A female voiding assist device for partial insertion in the bladder of a person. The device is a flexible catheter having a proximal end and a distal end and openings along the length thereof. The proximal end is set in a curl and is adapted to be inserted within the bladder. At least a portion of said device is positioned within the urethra of a person. An actuation device extends from a point adjacent the distal end to a point adjacent the sphincter whereby the actuation device is urged outwardly of the sphincter to permit voiding the bladder.The method of facilitating female voiding involves inserting within a female person the aforesaid catheter.
    Type: Grant
    Filed: October 9, 1990
    Date of Patent: January 5, 1993
    Inventor: Kenneth Weisman